^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Pancreatic Adenocarcinoma |
| Regimen: | GTX (capecitabine + docetaxel + gemcitabine) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Pancreatic Adenocarcinoma...The panel includes the combination of gemcitabine, docetaxel, and capecitabine (GTX regimen) as a category 2B recommendation for the treatment of patients with metastatic or locally advanced disease and good performance status.
